サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1663515

CRISPR・Cas遺伝子の世界市場：製品別・用途別・エンドユーザー別・国別・地域別 - 産業分析、市場規模・シェア、将来予測 (2025年～2032年)

CRISPR and Cas Gene Market, By Product, By Application, By End-User, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032

出版日
ページ情報
英文 303 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
CRISPR・Cas遺伝子の世界市場：製品別・用途別・エンドユーザー別・国別・地域別 - 産業分析、市場規模・シェア、将来予測 (2025年～2032年)
出版日: 2025年01月04日
発行: AnalystView Market Insights
ページ情報: 英文 303 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

レポートハイライト

CRISPR・Cas遺伝子の市場規模は2024年に48億9,943万米ドルと評価され、2025年から2032年にかけて16.90%のCAGRで拡大

CRISPR・Cas遺伝子の市場力学

医療と農業における精密な遺伝子編集ツールに対する需要の高まり

CRISPR・Casシステムのような精密な遺伝子編集ツールに対する需要は、その変革の可能性と費用対効果により、医療と農業で急増しています。医療では、CRISPRは病気の原因となる変異を直接修正することで、遺伝子疾患に対する画期的な治療を可能にします。例えば、鎌状赤血球貧血やベータサラセミアの治療において有望な結果を示しています。さらに、この技術はがん免疫療法においても極めて重要であり、遺伝子操作されたT細胞が特定の腫瘍細胞を標的とすることで、個別化医療を進展させます。数百万人に影響を及ぼしている遺伝性疾患の世界の増加は、治療研究にCRISPR技術を採用する重要な推進力となっています。世界保健機関（WHO）によると、約1万種類の単発性疾患が遺伝子編集の進歩によって治療できる可能性があるといいます。農業分野では、CRISPRは作物工学を再定義し、科学者が害虫抵抗性、干ばつ耐性、栄養強化作物を開発し、食糧不安と闘うことを可能にしています。また、化学農薬や化学肥料への依存を減らすことで、持続可能な農業を支えています。米国農務省（USDA）は2023年、遺伝子編集作物が今後10年間で食糧生産を最大30％押し上げる可能性があると報告し、この技術が世界の農業課題に対処できる可能性を強調しています。これらの分野でCRISPRの採用が増加しているのは、ZFNやTALENのような旧来の技術に比べ、その精密さ、効率性、手頃な価格によるものであり、医療と食糧生産の両分野におけるゲームチェンジャーとなっています。

CRISPR・Cas遺伝子市場：主な考察

  • 当社のリサーチアナリストが共有した分析によると、世界市場は予測期間（2025-2032年）に約16.90%のCAGRで毎年成長すると予測されています。
  • 製品別では、CRISPR製品が2024年に最大市場シェアを示すと予測されました。
  • エンドユーザー別では、製薬・バイオテクノロジー企業が2024年の主要企業です。
  • 地域別では、北米が2024年に主要な収益源となりました。

CRISPR・Cas遺伝子市場：セグメンテーション分析

世界のCRISPR・Cas遺伝子市場は、製品、用途、エンドユーザー、地域に基づいてセグメント化されます。

市場は製品によって2つのカテゴリーに分けられます：CRISPR製品とCRISPRサービスです。CRISPR製品は、遺伝子編集、研究、治療開発において広く応用されており、比類のない精度と効率を提供するため、市場を独占しています。ユーザーフレンドリーなキット、試薬、高度なCasタンパク質が入手可能になったことで、医療、農業、バイオテクノロジー業界全体で急速な普及が進んでいます。

市場はエンドユーザーに基づき、製薬・バイオテクノロジー企業、学術・研究機関、CROの3つに分類されます。製薬・バイオテクノロジー企業は、創薬、遺伝子疾患治療、個別化医療開発のための遺伝子編集技術に大規模な投資を行っており、市場を独占しています。彼らの強固な研究インフラと臨床試験への注力は、革新的なCRISPRベースのソリューションの商業化を加速し、市場成長を促進しています。

CRISPR・Cas遺伝子市場：地域別分析

CRISPR・Cas遺伝子市場は、技術の進歩、研究資金、規制の枠組み、市場導入の違いにより、地域差が顕著に現れています。北米が世界市場をリードしているのは、遺伝子編集技術への多額の投資、堅調なバイオテクノロジー産業、政府の支援政策によります。特に米国は、主要製薬企業と研究機関の間で広範な研究イニシアティブと共同研究が行われているため、優位を占めています。米国国立衛生研究所（NIH）によると、米国政府は近年CRISPR関連の研究プロジェクトに10億米ドル以上の資金を割り当てています。欧州は、強力な学術研究インフラと治療応用におけるCRISPR技術の採用増加により、顕著な市場シェアを占めています。ドイツ、英国、フランスなどの国々は、特に農業バイオテクノロジーと精密医療においてCRISPRイノベーションの最前線にいます。しかし、遺伝子組み換えに関する規制上の制約は依然として課題です。アジア太平洋は、主に中国、日本、韓国のような国々におけるバイオテクノロジー産業の拡大に後押しされ、急速な成長を遂げています。中国は主要なプレーヤーとして台頭し、特に農業と疾病治療における遺伝子編集研究と臨床応用に積極的な投資を行っています。この地域では、食糧安全保障と個別化医療への関心が高まっており、需要がさらに加速しています。ラテンアメリカや中東・アフリカの新興市場では、農業の進歩や医療の近代化を背景に、CRISPR技術の採用が徐々に進んでいます。

CRISPR・Cas遺伝子市場：競合情勢

CRISPR・Cas遺伝子市場は競争が激しく、既存プレーヤーと新興バイオテクノロジー企業が混在し、さまざまな用途でイノベーションを推進しています。市場各社は、製薬、バイオテクノロジー、農業分野からの需要増に対応するため、遺伝子編集キット、試薬、CRISPR関連サービスなど、CRISPRをベースとした先進製品の開発に注力しています。これらの企業は、CRISPR技術の精度、効率、拡張性を高めるための研究開発に多額の投資を行っており、これは商業化の成功に不可欠です。競合情勢は、製品ポートフォリオと市場リーチの拡大を目的とした戦略的パートナーシップ、提携、買収によって特徴付けられます。主なプレーヤーはまた、新しい遺伝子編集ツールや治療法の開発を加速するために、学術機関や研究機関との提携に取り組んでいます。さらに、各社は競争優位性を獲得するために、産業バイオテクノロジーや環境アプリケーションなど、従来の医療・農業以外の用途を模索することで、提供する製品を多様化しています。CRISPRベースの治療薬や農業製品に対する規制当局の承認が進む中、市場関係者は新興市場での長期的成長を目指しており、多様な規制環境を乗り切るための機会と課題の両方が存在します。全体として、競合は技術の進歩、革新、戦略的事業拡大によって激しくなっています。

目次

第1章 CRISPR・Cas遺伝子市場の概要

  • 調査範囲
  • 市場推定期間

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 CRISPR・Cas遺伝子の主な市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 CRISPR・Cas遺伝子市場：産業分析

  • PEST分析
  • ポーターのファイブフォース分析
  • 市場成長の見通し：マッピング
  • 規制体制の分析

第5章 CRISPR・Cas遺伝子市場：高まる地政学的緊張の影響

  • COVID-19パンデミックの影響
  • ロシア・ウクライナ戦争の影響
  • 中東紛争の影響

第6章 CRISPR・Cas遺伝子の市場情勢

  • CRISPR・Cas遺伝子の市場シェア分析 (2024年)
  • 主要メーカー別の内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 CRISPR・Cas遺伝子市場：製品別

  • 概要
    • セグメント別シェア分析：製品別
    • CRISPR製品
    • CRISPRサービス

第8章 CRISPR・Cas遺伝子市場：用途別

  • 概要
    • セグメント別シェア分析：用途別
    • バイオ医薬品用途
    • 農業用途
    • 産業用途

第9章 CRISPR・Cas遺伝子市場：エンドユーザー別

  • 概要
    • セグメント別シェア分析：エンドユーザー別
    • 製薬・バイオテクノロジー企業
    • 学術・研究機関
    • CRO (医薬品開発業務受託機関)

第10章 CRISPR・Cas遺伝子市場：地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • オランダ
    • スウェーデン
    • ロシア
    • ポーランド
    • その他
  • アジア太平洋（APAC）
    • 概要
    • アジア太平洋の主要メーカー
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • インドネシア
    • タイ
    • フィリピン
    • その他
  • ラテンアメリカ（LATAM）
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東・アフリカ (MEA)
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第11章 主要ベンダー分析：CRISPR・Cas遺伝子業界

  • 競合ダッシュボード
    • 競合ベンチマーク
    • 競合ポジショニング
  • 企業プロファイル
    • Thermo Fisher Scientific
    • Editas Medicine
    • CRISPR Therapeutics
    • Intellia Therapeutics
    • Caribou Biosciences
    • Horizon Discovery
    • Synthego Corporation
    • Agilent Technologies
    • GenScript Biotech
    • Takara Bio
    • Promega Corporation
    • MilliporeSigma
    • Bio-Rad Laboratories
    • New England Biolabs
    • Beam Therapeutics
    • Others

第12章 AnalystViewの全方位的分析

目次
Product Code: ANV4717

REPORT HIGHLIGHT

CRISPR and Cas Gene Market size was valued at US$ 4,899.43 Million in 2024, expanding at a CAGR of 16.90% from 2025 to 2032.

CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) and Cas (CRISPR-associated) Genes form a groundbreaking gene-editing technology that allows precise alterations in DNA sequences. CRISPR acts as a natural immune defense mechanism in bacteria, while Cas proteins (such as Cas9) serve as molecular scissors guided by RNA to cut specific DNA strands. This system's ability to edit genes with unmatched accuracy has revolutionized genetic research and therapeutic development. The need for CRISPR-Cas technology stems from its potential to address genetic disorders by directly modifying faulty genes. Unlike traditional gene therapies, CRISPR is faster, cost-effective, and more precise, making it a superior choice for treating inherited diseases. It plays a pivotal role in personalized medicine, where tailored genetic interventions offer targeted treatment. Moreover, in agriculture, CRISPR enhances crop yields, pest resistance, and nutritional content, improving global food security. CRISPR's importance lies in its vast applications across healthcare, agriculture, and scientific research. It offers hope for curing genetic diseases like cystic fibrosis and sickle cell anemia, drives innovation in cancer immunotherapy, and aids in developing new antiviral treatments. Additionally, it empowers fundamental biological research by enabling detailed studies of gene functions. CRISPR-Cas technology continues to reshape science, holding transformative potential for human health and sustainability.

CRISPR and Cas Gene Market- Market Dynamics

Rising demand for precise gene-editing tools in healthcare and agriculture

The demand for precise gene-editing tools like CRISPR-Cas systems is surging in healthcare and agriculture due to their transformative potential and cost-effectiveness. In healthcare, CRISPR enables groundbreaking therapies for genetic disorders by directly correcting disease-causing mutations. For instance, it has shown promising results in treating sickle cell anemia and beta-thalassemia. Additionally, the technology is pivotal in cancer immunotherapy, where engineered T cells target specific tumor cells, advancing personalized medicine. The global rise in genetic disorders, affecting millions, is a key driver for adopting CRISPR technology in therapeutic research. According to the World Health Organization (WHO), approximately 10,000 monogenic diseases can potentially be treated through gene-editing advancements. In agriculture, CRISPR is redefining crop engineering, allowing scientists to develop pest-resistant, drought-tolerant, and nutritionally enhanced crops to combat food insecurity. It supports sustainable farming by reducing dependence on chemical pesticides and fertilizers. The U.S. Department of Agriculture (USDA) reported in 2023 that gene-edited crops could boost food production by up to 30% over the next decade, emphasizing the technology's potential to address global agricultural challenges. The rising adoption of CRISPR across these sectors is driven by its precision, efficiency, and affordability compared to older techniques like ZFNs and TALENs, making it a game-changer in both medicine and food production.

CRISPR and Cas Gene Market- Key Insights

  • As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 16.90% over the forecast period (2025-2032)
  • Based on Product segmentation, CRISPR Products was predicted to show maximum market share in the year 2024
  • Based on End-User segmentation, Pharmaceutical and Biotechnology Companies was the leading segment in 2024
  • On the basis of region, North America was the leading revenue generator in 2024

CRISPR and Cas Gene Market- Segmentation Analysis:

The Global CRISPR and Cas Gene Market is segmented on the basis of Product, Application, End-User, and Region.

The market is divided into two categories based on Product: CRISPR Products, and CRISPR Services. CRISPR Products dominate the market due to their widespread application in gene editing, research, and therapeutic development, offering unmatched precision and efficiency. The availability of user-friendly kits, reagents, and advanced Cas proteins has driven rapid adoption across healthcare, agriculture, and biotechnology industries.

The market is divided into three categories based on End-User: Pharmaceutical and Biotechnology Companies, Academic and Research Institutions, and Contract Research Organizations. Pharmaceutical and Biotechnology Companies dominate the market due to their extensive investments in gene-editing technologies for drug discovery, genetic disease therapies, and personalized medicine development. Their robust research infrastructure and focus on clinical trials accelerate the commercialization of innovative CRISPR-based solutions, driving market growth.

CRISPR and Cas Gene Market- Geographical Insights:

The CRISPR and Cas gene market exhibits significant regional variations driven by differences in technological advancements, research funding, regulatory frameworks, and market adoption. North America leads the global market, attributed to substantial investments in gene-editing technologies, a robust biotechnology industry, and supportive government policies. The United States, in particular, dominates due to extensive research initiatives and collaborations between leading pharmaceutical companies and research institutions. According to the National Institutes of Health (NIH), the U.S. government allocated over $1 billion in funding for CRISPR-related research projects in recent years. Europe holds a prominent market share, driven by strong academic research infrastructure and rising adoption of CRISPR technologies in therapeutic applications. Countries like Germany, the United Kingdom, and France are at the forefront of CRISPR innovations, particularly in agricultural biotechnology and precision medicine. However, regulatory constraints around genetic modifications remain a challenge. Asia-Pacific is experiencing rapid growth, primarily fueled by expanding biotechnology industries in countries like China, Japan, and South Korea. China has emerged as a major player, with aggressive investments in gene-editing research and clinical applications, especially in agriculture and disease treatment. The region's rising focus on food security and personalized medicine further accelerates demand. Emerging markets in Latin America and the Middle East & Africa are gradually adopting CRISPR technologies, driven by agricultural advancements and healthcare modernization.

CRISPR and Cas Gene Market- Competitive Landscape:

The CRISPR and Cas gene market is highly competitive, with a mix of established players and emerging biotech firms driving innovation across various applications. Companies in the market are focusing on developing advanced CRISPR-based products, such as gene-editing kits, reagents, and CRISPR-related services, to cater to the increasing demand from the pharmaceutical, biotechnology, and agricultural sectors. These companies invest heavily in research and development to enhance the precision, efficiency, and scalability of CRISPR technology, which is vital for successful commercialization. The competitive landscape is characterized by strategic partnerships, collaborations, and acquisitions aimed at expanding product portfolios and market reach. Key players are also engaging in alliances with academic institutions and research organizations to accelerate the development of new gene-editing tools and therapies. In addition, companies are diversifying their offerings by exploring applications beyond traditional healthcare and agriculture, such as industrial biotechnology and environmental applications, to gain a competitive edge. With growing regulatory approval for CRISPR-based therapies and agriculture products, market players are positioning themselves for long-term growth in emerging markets, which presents both opportunities and challenges in navigating diverse regulatory environments. Overall, the competition is intense, driven by technological advancements, innovation, and strategic business expansion.

Recent Developments:

  • In April 2024, Cellistic successfully acquired the STAR-CRISPR Cas-12 gene-editing technology platform and its full intellectual property portfolio from Artisan Bio, enhancing its capabilities in iPSC-based allogeneic cell therapy. This acquisition strengthens Cellistic's position as a leader in gene editing, offering high precision and efficiency in cell therapy development, and allows for custom edits with greater precision than conventional CRISPR technologies.
  • In July 2024, Ncardia acquired STAR-CRISPR technology to enhance gene editing in induced pluripotent stem cells (iPSCs), offering high efficiency in gene knock-ins and knock-outs with minimal off-target effects. This acquisition strengthens their capabilities in drug discovery and regenerative medicine by providing more accurate disease models and advanced cell therapies.
  • In March 2024, Ricoh entered a licensing agreement with ERS Genomics for access to CRISPR/Cas9 genome editing technology in the USA and Japan. This collaboration, combined with Ricoh's acquisition of Elixirgen Scientific, aims to accelerate drug discovery, personalized medicine, and regenerative medicine by leveraging CRISPR to create reliable disease models, improving drug development timelines and success rates.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL CRISPR AND CAS GENE MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Thermo Fisher Scientific
  • Editas Medicine
  • CRISPR Therapeutics
  • Intellia Therapeutics
  • Caribou Biosciences
  • Horizon Discovery
  • Synthego Corporation
  • Agilent Technologies
  • GenScript Biotech
  • Takara Bio
  • Promega Corporation
  • MilliporeSigma
  • Bio-Rad Laboratories
  • New England Biolabs
  • Beam Therapeutics
  • Others

GLOBAL CRISPR AND CAS GENE MARKET, BY PRODUCT- MARKET ANALYSIS, 2019 - 2032

  • CRISPR Products
  • CRISPR Services

GLOBAL CRISPR AND CAS GENE MARKET, BY APPLICATION - MARKET ANALYSIS, 2019 - 2032

  • Biomedical Applications
  • Agricultural Applications
  • Industrial Applications

GLOBAL CRISPR AND CAS GENE MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Pharmaceutical and Biotechnology Companies
  • Academic and Research Institutions
  • Contract Research Organizations

GLOBAL CRISPR AND CAS GENE MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. CRISPR and Cas Gene Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. CRISPR and Cas Gene Market Snippet by Product
    • 2.1.2. CRISPR and Cas Gene Market Snippet by Application
    • 2.1.3. CRISPR and Cas Gene Market Snippet by End-User
    • 2.1.4. CRISPR and Cas Gene Market Snippet by Country
    • 2.1.5. CRISPR and Cas Gene Market Snippet by Region
  • 2.2. Competitive Insights

3. CRISPR and Cas Gene Key Market Trends

  • 3.1. CRISPR and Cas Gene Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. CRISPR and Cas Gene Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. CRISPR and Cas Gene Market Opportunities
  • 3.4. CRISPR and Cas Gene Market Future Trends

4. CRISPR and Cas Gene Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. CRISPR and Cas Gene Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. CRISPR and Cas Gene Market Landscape

  • 6.1. CRISPR and Cas Gene Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. CRISPR and Cas Gene Market - By Product

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product, 2024 & 2032 (%)
    • 7.1.2. CRISPR Products
    • 7.1.3. CRISPR Services

8. CRISPR and Cas Gene Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
    • 8.1.2. Biomedical Applications
    • 8.1.3. Agricultural Applications
    • 8.1.4. Industrial Applications

9. CRISPR and Cas Gene Market - By End-User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End-User, 2024 & 2032 (%)
    • 9.1.2. Pharmaceutical and Biotechnology Companies
    • 9.1.3. Academic and Research Institutions
    • 9.1.4. Contract Research Organizations

10. CRISPR and Cas Gene Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. CRISPR and Cas Gene Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. CRISPR and Cas Gene Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.8. UK
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. UK Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.8.4. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.8.5. UK Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.9. France
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. France Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.9.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.9.5. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.10. Italy
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. Italy Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.10.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.10.5. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.11. Spain
      • 10.3.11.1. Overview
      • 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.3. Spain Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.11.5. Spain Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.12. The Netherlands
      • 10.3.12.1. Overview
      • 10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.3. The Netherlands Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.12.4. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.12.5. The Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Overview
      • 10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.13.5. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.14. Russia
      • 10.3.14.1. Overview
      • 10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.3. Russia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.14.5. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.15. Poland
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Poland Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.16. Rest of Europe
      • 10.3.16.1. Overview
      • 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.16.3. Rest of the Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.16.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.16.5. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. CRISPR and Cas Gene Key Manufacturers in Asia Pacific
    • 10.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.4.5. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.6. APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.7. China
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. China Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.7.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.7.5. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.8. India
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. India Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.8.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.8.5. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.12. Indonesia
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Indonesia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.13. Thailand
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Thailand Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.5. Latin America (LATAM)
    • 10.5.1. Overview
    • 10.5.2. CRISPR and Cas Gene Key Manufacturers in Latin America
    • 10.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.5.5. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.6. LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa (MEA)
    • 10.6.1. Overview
    • 10.6.2. CRISPR and Cas Gene Key Manufacturers in Middle East and Africa
    • 10.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.6.5. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.6. MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.8. UAE
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. UAE Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.8.4. UAE Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.8.5. UAE Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- CRISPR and Cas Gene Industry

  • 11.1. Competitive Dashboard
    • 11.1.1. Competitive Benchmarking
    • 11.1.2. Competitive Positioning
  • 11.2. Company Profiles
    • 11.2.1. Thermo Fisher Scientific
    • 11.2.2. Editas Medicine
    • 11.2.3. CRISPR Therapeutics
    • 11.2.4. Intellia Therapeutics
    • 11.2.5. Caribou Biosciences
    • 11.2.6. Horizon Discovery
    • 11.2.7. Synthego Corporation
    • 11.2.8. Agilent Technologies
    • 11.2.9. GenScript Biotech
    • 11.2.10. Takara Bio
    • 11.2.11. Promega Corporation
    • 11.2.12. MilliporeSigma
    • 11.2.13. Bio-Rad Laboratories
    • 11.2.14. New England Biolabs
    • 11.2.15. Beam Therapeutics
    • 11.2.16. Others

12. 360 Degree AnalystView

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us